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To check the stimulatory potency of the tetrahydro f rms of the two major pteridines o~urring in human tissues, neoptcrin and biopterin, NO 
synthase was purified 6000-fold from human cerebellum. Tetrahydrobiopterin st mulated the activity up to 4.5-fold in a concentration dependent 
manner with a maximum above 1/tM, whereas tetrah~,droneopterin was completely inactive in concentrations up to 100/.tM. Tetrahydrobiopterin, 
bat not neopterin derivatives, were copurified with the NO synthase activity. Our results demonstrate that human cerebellum contains a tetrnhy- 
drobiopterin dependent NO synthaae activity. 
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1. INTRODUCTION 
Nitric oxide (NO) is a labile, diffusible molecule; 
which is thought o be involved in a variety of  biologi- 
cally important phenomena such as neurotransmission, 
blood pressure regulation and cytotoxieity (for review 
see e.g. [1]). Nitric oxide is formed from L-arginine by 
NO synthase, an enzyme which has been found to occur 
in at least two different forms, a cytokine-inducible, 
caleimn independent and a constitutive, calcium de- 
pendent ype. With the cytokine inducible type from 
muHne macrophages, tetrahydrobiopterin has been 
identified as the cytosolie component required for full 
activity of the enzyme [2,3]. Subsequently, also the cal- 
cium dependent, constitutive form of NO synthase iso- 
lated from porcine cerebellum [4], rat cerebellum [5] or 
bovine endothelial cells [6] was found to be stimulated 
by tetrahydrobiopterin. Moreover, studies with intact 
cells revealed that intracellular concentrations of 
tetrahydrobiopterin l mit the amount of nitric oxide 
formed from L-arginine in cytokine treated murine fi- 
broblasts [7] and brain endothelial cells [8] as well as in 
• porcine endothelial cells [9]. The studies •investigating 
stimulator), action of  pteridines to NO synthase prepa- 
rations from non-human sources revealed a remarkable 
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Specificity for 6-/~-tetrahydrobiopterin. In addition, 
tetrahydrobiopterin was found to be bound to the en- 
zyme purified from porcine cerebellum [10]. 
Like other mammals, humans are able to synthesize 
tetrahydrobiopterin from guanosine 5'-triphosphate 
(OTP). Pteridine metabolism of humans is, however, 
peculiar in the accumulation of neopterin derivatives in 
addition to biopterin in cells [11], tissues and fluids [12]. 
The finding o f  7-neopterin derivatives in human urine 
suggests that a tetrahydroneopterin species might be 
involved in hydroxylation-type r actions in humans 
[13]. We were interested, therefore, whether human NO 
synthase can bind and utilize tetrahydroneopterin or 
tetrahydrobiopterin for stimulation of its activity, For 
this purpose, we purified NO synthase from human 
cerebellum, compared the stimulatory potency • of the 
tetrahydro forms of biopterin and neopterin and 
checked the pteridine content of the cerebellum homo- 
genate versus that of the purified preparation. 
1. MATERIALS AND METHODS 
Human cerebella were obtained from the DeparUnent ofForensic 
Medicine of the University of Innsbruck, which had been dedicated 
to scientific research observing the respective Austrian laws. Cerebella 
were collected 10-40 h post-mortem and stored for up to 30 days at 
-80°C. Preparation of the enzyme was carried out using a protocol 
optimized for porcine cerebellum [4]. Briefly, the tissue (900 g) was 
homogenized with an Ultra Turrax in 3 volumes of a 50 mM trietha- 
nolamine- HCI buffer, pH 7.5, containing 0.5 mM EDTA (buffer A), 
and the homoge|iate wa~ centrifuged at10,000 × g for 30 mia. Solid 
ammonium sulfate (176 ~1; 30% saturation) was added to the sapcrna- 
tent, followed by centrifugation at 10,000 × g for 15 rain. The pellet 
was washed once with buffer A containing ammonium sulfate (30% 
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saturation) and was subsequently resuspeaded in a 20 mM trietha- 
nolamine-HCl buffer, pH 7.5, containing 0.5 mM EDTA and 10 mM 
mereaptoethanol (buffer B) followed b2/a further ccntrifugation for 
40 min at 10000 x g. The super~atant was incubated for 30 rain with 
10 ml of 2',5'.ADP.Scpharose (Pharmacia, Freiburg, Germany) and 
then poured into a column. The Sepharose was washed with 100 ml 
buffer B containing 1ram NADPH. NO synthase was eluted witli 30 
ml of buffer B containing 10 mM NADPH and concentrated by 
ultrafiltration (Cer.tricon 30 from Amigoa, Witten, Germany). Protein 
was determined according to Bradford [14], with pure bovine serum 
alhumin¢ (Scrva, Heidelberg, Germany) as standard. 
Sodium dodeeylsulfate/polyacr/lamide gel electrophoresis (SOS/ 
PAGE) and immunoblotting were performed as previouzly deserlbed 
[15]. Purified NO synthase (5-20 ng) was subjected to SDS/PAGE 
using 8% slab gels according to Laemmli [16] and eleetrophoretically 
transferred to riitroeellulose membranes in 25 mM Tris-HCl, pH 8.3, 
containing 192 mM glycine, 0.02% (m/v) SDS and 20% (by vol.) meth- 
anol at 250 mA for 100 rain. The membranes were incubated with a 
pol),clonal antiserum raised against the porcine cerebellum enzyme [4], 
followed by incubation with horseradish peroxidase labelled anti-rab- 
bit I~G antibodies. The bands were vi.~aalized with the EeL Western 
blotting detection s:/stem (Amersham Buehler, Braunsehweig, Ger- 
many) according to the reeommcndation~ of the company. 
Determination fpteridin¢~ was performed subsequent to oxidation 
by iodine in acidic or alkaline media according to Fukushima nd 
Nixon [17]. Briefly, 100/el were mixed with 5/el 1 N HCI (for determi- 
nation of the total anaount of pteridines) or 5/el 1 N NaOH (for the 
determination ofalkali stable 7,8-dihydrobiopterin a d biopterin) and 
5/el of 0.1 M iodine (zolabilized in 0.25 M potassium iodide) added, 
Subscquertt toincubation at room temperature in the dark for I h, 10 
/el I M HCl.were added to the alkaline incubation mixture and 10/el 
0.I M aseorbic acid were-added to both mixtur¢~. These acidic solu- 
tions were then applied to solid phase cartridges (SEX, Varian, Pale 
Alto, CA, USA), processed and directly introduced into an HPLC 
system by an AASP module (Varian)as described [18]. Pteridines were 
separated with a reversed phase C-18 column (Lichrospher, 250 mm 
x 4 mm i.d., 5/~m particle ~ize, Merck, Darmstadt, Germany) elated 
with 0.015 M potassium phosphate buffer, pH 6.0 at a flow rate o1"0.8 
ml/min and detected by fleered.once ( xcitation 350 nm, emission 440 
am). 
was determined as formation of [ H]citrullin¢ NO synthase activity 
from [~l'l]L-arginine as described [19]. NO synthase incubations were 
carried out at 370C for 15 rain in total volumes of 0.1 ml era 50 mM 
triethanolamine-HCl buffer, pH 7.0, containing 0.1 mM L-[2,3-~H] - 
arginine (50,000 to 100,000 epm), 0.1 mM NADPH, 5/aM FAD, 10 
/~8/ml ealmodulin, 3/aM free Ca "-+ and 10/aM 6-R-tetrahydrobiop- 
terin. In some cases (Fig. 1); varying concentrations of 6-R-tetrahy- 
drobiopterin 6r 6-R,S-tetrahydroneopterin (both from Dr. Sehireks 
Laboratories, Joan, Switzerland) were used instead of 10/aM 6-R- 
tetrahydrobiopterin. Free calcium concentrations were adjusted using 
mixtures of MgCl2, CaCl:, EDTA and EGTA as described [20]. For 
the determination of the stoichiometry of nitrite plus nitrate to oit. 
rulline, conditions were modified to 40 mM Tris-HCl, pH 8.0, contain. 
ing 25/aM FAD, 25/aM FMN, 2 mM NADPH, and an NADPH 
regenerating system (0.25 U/ml glucose 6.phosphate del~ydrogeuas¢ 
(Serve) and 20 mM glucose f-phosphate) was addedand the incuba- 
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Fig. 1. Stimulation of human NO syntha~ by the tetrahydroforms of 
neopterin (O) and biopterin COL Data represent mean values:l:S.E.M. 
(n=3). 
tion carried oat for 3 h at 370C. Nitrate was reduteA by nitrate 
reduetase (Serva, 1.25 U/ml plus 2.5 mM freshly dissolved NADPH 
for l h at room temperature) and nitrite was subsequently determined 
by the Griess reaction with the method of Gr in  et el. [21], asia8 the 
stable Griess reagent form Merck. 
3. RESULTS AND DISCUSSION 
As shown in Table  I, NO synthas¢ was purified 6 ,000-"  
fold f rom a 10,000 × g supernatant  Of human cerebella 
with a recovery o f  3%. F rom 900 g o f  tissue, 80/ag of  
protein were obta ined with a specific activity o f  180 
nmol  citrulline x mg -~ x min "t. The purity o f  the enzyme 
preparat ion was about  20% as judged f rom Coomassie 
blue stained SDS gels. In Western blots, a rabbit anti- 
serum raised against purified porcine cerebellar NO 
synthase recognized one single band with an apparent  
molecular  mass o f  160 kDa.  The human enzyme con- 
verted L-arginine into equal amounts  o f  eitrulline and 
NO, . - /NO3-  in a Ca2*-dependent manner.  Tetrahydro-  
biopterin st imulated NO synthase up to 4-fold with an 
ECso o f  about  0.2/aM arid a maximal ly effective concen-  
tration of  1 btM, but  tetrahydroneopter in was com- 
pletely inactive in concentrat ions up to 100/JM (Fig. 1). 
The cerebel lum homogenate  contained both neopterin 
and biopterin derivatives (6.2+_0.7 and 5.6+0.4 pmol /mg 
of  protein,  respectively, mean+_SD, n=3). In contrast,  
only biopterin (227 pmol /mg o f  protein) remains bound 
to the enzyme upon purif ication (Fig. 2). Loss o f  the 
Table I 
Purification of NO synthase from human cerebellum 
Fraction Protein Specific 
(me) activity 
(nmol.mg-~.m!n -~) 
Recovery 
(°1ol 
Purification 
factor 
I 0,000 × g Sulmrnatant 
Ammonium sulfate precipitate 
2',5'-ADP-Sepharose eluate 
Ultrafiltration oon~ntrat¢ 
15,6~ 0.03 1~ 
1170 0.14 35 
0.26 81.1 4.5 
0.08 181.3 3.1 
1 
4.7 
2703 
6043 
161 • 
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Fig. 2. HPLC profiles of pteridines in the human NO synthase prepa- 
ration and the crude cerebellum h0mogenate. 
biopterin peak upon alkaline oxidation indicates that 
more than 90% of the biopterin bound to human NO 
synthase is present in the tetrahydro form. 
These results demonstrate that human cerebellum 
comains a Ca~-÷-dependent NO synthase activity, which 
is selectively stimulated by tetrahydrobiopterin. Using 
calmodulin antagonists, Schmidt and Murad have 
shown that the calcium dependence is mediated by 
calmodulin [22]. 
The clear failure of neopterin derivatives to bind to 
NO synthase or to stimulate its activity render unlikely 
the possibility that 7-neopterin derivatives found in 
human urine [13] originate from a turnover of the 1~O 
synthase reaction. Tetrahydrobiopterin deficiency in 
human brain can occur in inherited disorders of the 
biosynthesis of tetrahydrobiopterin from GTP as well 
as by deficiencies of the dihydropteridine reductase an. 
zyme, which keeps the cofactor in its active tetrahydro 
form. It is well known that these inherited disorders of 
tetrahydrobiopterin •synthesis and/or recycling lead to 
severe mental retardation (reviewed in [23]). Milder 
forms of tetrahydrobiopterin deficiency have been ob. 
served in several neurological disorders [23]. Our results 
suggest hat, in addition to the known roles of tetrahy- 
drobiopterin in the hydroxylation of aromatic amino 
acids in neurotransmitter synthesis [24--26], tetrahydro- 
biopterin deficiency •might also lead to impaired NO 
formation in human brain and this might contribute to 
the neurological symptoms observed. 
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